handshake-1
miodrag ignjatovic / iStockphoto.com
18 July 2018Americas

AbbVie and Mylan agree Humira licensing deal

US-based biopharmaceutical company AbbVie entered into a patent licensing agreement with generics company Mylan yesterday.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
14 May 2026   Isomorphic Labs said the funding round, led by venture firm Thrive Capital, would be used to further its drug design engine and support hiring targets.
Americas
14 May 2026   The agreement is the latest in a string of major deals between Hengrui and multinational drugmakers, and will see the parties jointly develop assets while licensing others.
Americas
13 May 2026   PureWick claims that two rivals infringed its external catheter and urine-management technology in their medical devices.